Lv32
340 积分 2022-03-09 加入
Individualized tumor-informed circulating tumor DNA analysis for postoperative monitoring of non-small cell lung cancer
1年前
已完结
Genetic Alterations Detected by Circulating Tumor DNA in HER2-Low Metastatic Breast Cancer
1年前
已完结
Safety and Tolerability of Low-Dose Radiation and Stereotactic Body Radiotherapy + Sintilimab for Treatment-Naïve Stage IV PD-L1+ Non–Small Cell Lung Cancer Patients
1年前
已完结
Collagen-related gene expression level predicts the prognosis and immune therapy response
1年前
已完结
DELFMUT: duplex sequencing-oriented depth estimation model for stable detection of low-frequency mutations
1年前
已完结
Dynamic circulating tumor DNA during chemoradiotherapy predicts clinical outcomes for locally advanced non-small cell lung cancer patients
1年前
已完结
Integrated multi-omics profiling yields a clinically relevant molecular classification for esophageal squamous cell carcinoma
1年前
已完结
Molecular classification of hormone receptor-positive HER2-negative breast cancer
1年前
已完结
Gene expression profile of high PD-L1 non-small cell lung cancers refractory to pembrolizumab
1年前
已完结
Camrelizumab plus apatinib as second-line treatment for advanced oesophageal squamous cell carcinoma (CAP 02): a single-arm, open-label, phase 2 trial
2年前
已完结
皖公网安备34019202002308
